Newsletter Subscribe
Enter your email address below and subscribe to our newsletter
Enter your email address below and subscribe to our newsletter

Rayner announced a significant update to its packaging, marking a pivotal step towards achieving its environmental objectives while also enhancing the customer experience. The company has introduced several innovative changes designed to reduce its carbon footprint and improve the practicality…

A recent study has introduced an innovative approach to treating retinal detachment through an artificial vitreous body made from alginate, a natural carbohydrate extracted from algae. This research represents a collaboration among experts from Pohang University of Science and Technology…

BlueRock Therapeutics LP, a clinical-stage cell therapy company and a subsidiary of Bayer, in partnership with Foundation Fighting Blindness, has announced their collaboration to introduce a new cohort to the Foundation’s ‘Uni-Rare natural history study’. This initiative focuses on individuals…

In a pivotal development in the field of ophthalmology, Nanodropper Inc announced that the results from a clinical trial evaluating the Nanodropper® Adaptor have been published in the esteemed journal, Ophthalmology. The study’s findings indicate that there was no clinically…
In a review published in MedComm – Future Medicine, a research team led by Gao Yuanxu from Macau University of Science and Technology, with Miao Hanpei of Southern Medical University as the first author, sheds light on the promising intersection…

A Freedom of Information (FOI) request has brought to light a concerning issue: thousands of blind and partially sighted individuals in England are being denied essential rehabilitation services, which are crucial for adapting to life after sight loss. This revelation…

Scientists at the University of Waterloo have made a groundbreaking development in eye care technology by creating a new type of contact lens that not only serves as a protective bandage for corneal wounds but also delivers healing drugs in…

In a landmark study that promises new hope for nearly 1.5 million people worldwide suffering from retinitis pigmentosa (RP), scientists at Columbia University Vagelos College of Physicians and Surgeons are pioneering a gene therapy that could potentially treat RP patients…

In a recent phase II clinical trial conducted by the National Eye Institute (NEI), part of the National Institutes of Health, the antibiotic minocycline, known for its anti-inflammatory properties, was tested for its efficacy in slowing down the progression of…

Research teams at Purdue University’s College of Engineering have been awarded two grants from the National Eye Institute, totaling an impressive $6.7 million. These funds are earmarked for the development of specialized smart soft contact lenses designed for the continuous monitoring…